Feasibility of Incorporating a Standardized Substance Use Measure With Linked-Brief Intervention Into Routine Psychosocial Care of Adult Childhood Cancer Survivors

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15+
SponsorSt. Jude Children's Research Hospital

About this trial

The ASSIST Study is designed to explore whether a brief, evidence based substance use screening and counseling approach can be easily integrated into routine survivorship care at St. Jude Children's Research Hospital.

During a regularly scheduled psychosocial visit, participants complete the World Health Organization's Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST). This short questionnaire helps identify patterns of use related to tobacco, alcohol, cannabis, prescription medications, and other substances. Survivors whose results show possible risk receive a brief, supportive counseling session during the same appointment. This session uses motivational interviewing techniques to help individuals reflect on their use and consider steps to reduce potential harm.

Primary Objective:

\- Assess the feasibility and acceptability of integrating a standardized substance use screening and brief intervention protocol into routine psychosocial workflows within a survivorship clinic.

Secondary Objective:

\- Evaluate the fidelity of delivering a brief substance use intervention to reduce substance use behaviors among survivors.

Eligibility criteria

Qualifiers

Followed in the ACT Clinic at St. Jude Children's Research Hospital

Greater than or equal to 15 years of age at time of evaluation

Able to speak and read English

Disqualifiers

Significant mental or cognitive impairment that would impact ability to complete surveys or participate in the brief intervention

Trial design

Treatments tested in this trial

  • WHO ASSIST v3.1 Screening with Feedback
  • ASSIST Linked Brief Intervention (10 Step Motivational interviewing (MI)/FRAMES)
  • WHO ASSIST v3.1 Screening (No Feedback)

Treatment groups

30 Participants
are divided into 2 treatment groups